All-trans retinoic acid remodels extracellular matrix and suppresses laminin-enhanced contractility of cultured human retinal pigment epithelial cells

Experimental Eye Research

Volumn 88, Issue 5, 2009, Pages 900-909

  Chang, Yo Chen ^a,b   Kao, Ying Hsien ^c   Hu, Dan Ning ^d   Tsai, Li Yu ^e   Wu, Wen Chuan ^b  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

anti adhesion therapy; collagen gel contraction; integrin V 3; integrin phosphorylation; laminin 1; tissue remodeling

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; LAMININ; RETINOIC ACID;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CELL ADHESION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LAMININ; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHORYLATION; RATS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN;

EID: 64849092290     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.11.028     Document Type: Article

References (50)

1. Axel D.I., Frigge A., Dittmann J., Runge H., Spyridopoulos I., Riessen R., Viebahn R., and Karsch K.R. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc. Res. 49 (2001) 851-862
2. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 1274-1278
3. Campochiaro P.A., Jerdon J.A., and Glaser B.M. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest. Ophthalmol. Vis. Sci. 27 (1986) 1615-1621
4. Campochiaro P.A., and Hackett S.F. Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components. Exp. Eye Res. 57 (1993) 539-547
5. Casaroli Marano R.P., and Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 35 (1994) 2791-2803
6. Chang S., Coleman D.J., Lincoff H., Wilcox Jr. L.M., Braunstein R.A., and Maisel J.M. Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am. J. Ophthalmol. 98 (1984) 180-188
7. Charteris D.G., Sethi C.S., Lewis G.P., and Fisher S.K. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye 16 (2002) 369-374
8. Dong X., Chen N., Xie L., and Wang S. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid. Retina 26 (2006) 210-213
9. Doyle J.W., Dowgiert R.K., and Buzney S.M. Factors modulating the effect of retinoids on cultured retinal pigment epithelial cell proliferation. Curr. Eye Res. 11 (1992) 753-765
10. Dutt K., Scott M.M., Del Monte M., Brennan M., Harris-Hooker S., Kaplan H.J., and Verly G. Extracellular matrix mediated growth and differentiation in human pigment epithelial cell line 0041. Curr. Eye Res. 10 (1991) 1089-1100
11. Elsdale T., and Bard J. Collagen substrata for studies on cell behavior. J. Cell Biol. 54 (1972) 626-637
12. Glaser B.M., Cardin A., and Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology 94 (1987) 327-332
13. Grierson I., Hiscott P.S., Hitchins C., McKechnie N.M., White V.A., and McLeod D. Which cells are involved in the formation of epiretinal membranes?. Semin. Ophthalmol. 2 (1987) 99-109
14. Hiscott P., Sheridan C., Magee R.M., and Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog. Retin. Eye Res. 18 (1999) 167-190
15. Hong W.K., Endicott J., Itri L.M., Doos W., Batsakis J.G., Bell R., Fofonoff S., Byers R., Atkinson E.N., Vaughan C., et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315 (1986) 1501-1505
16. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., Byers R.M., Schantz S.P., Kramer A.M., Lotan R., Peters L.J., et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323 (1990) 795-801
17. Ho T.C., Del Priore L.V., and Kaplan H.J. En bloc transfer of extracellular matrix in vitro. Curr. Eye Res. 15 (1996) 991-997
18. Hu D.N., McCormick S.A., Ritch R., and Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest. Ophthalmol. Vis. Sci. 33 (1993) 2210-2219
19. Hu D.N., Savage H., and Roberts J.E. Uveal melanocytes, ocular pigment epithelium and Mueller cells in culture: in vitro toxicology. Int. J. Toxicol. 21 (2002) 465-472
20. Jerdan J.A., Pepose J.S., Michels R.G., Hayashi H., de Bustros S., Sebag M., and Glaser B.M. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 96 (1989) 801-810
21. Kampik A., Kenyon K.R., Michels R.G., Green W.R., and de la Cruz Z.C. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch. Ophthalmol. 99 (1981) 1445-1454
22. Kirchhof B., and Sorgente N. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev. Ophthalmol. 16 (1989) 1-53
23. Kishi H., Mishima H.K., and Yamashita U. Effects of retinoic acid and TGF-beta 1 on the proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Curr. Eye Res. 17 (1998) 483-486
24. Kishi H., Kuroda E., Mishima H.K., and Yamashita U. Role of TGF-beta in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol. Int. 25 (2001) 1125-1129
25. Kramer R.H., Cheng Y.F., and Clyman R. Human microvascular endothelial cells use beta 1 and beta 3 integrin receptor complexes to attach to laminin. J. Cell Biol. 111 (1990) 1233-1243
26. Lemor M., de Bustros S., and Glaser B.M. Low-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferation. Arch. Ophthalmol. 104 (1986) 1223-1225
27. Liu X., Lü L., Tao B.B., and Zhu Y.C. All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells. Acta Pharmacol. Sin. 29 (2008) 1035-1041
28. MacDonald I.M., Peters C., and Chen M.H. Effect of retinoic acid on wound healing of laser burns to porcine retinal pigment epithelium. Can. J. Ophthalmol. 31 (1996) 175-178
29. Machemer R. Massive periretinal proliferation: a logical approach to therapy. Trans. Am. Ophthalmol. Soc. 75 (1977) 556-586
30. Machemer R., and Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am. J. Ophthalmol. 80 (1975) 1-23
31. Marmor M.F. The retinal pigment epithelium: function and disease. In: Marmor M.F., and Wolfensbeger T.J. (Eds). Structure, Function and Disease of the Retinal Pigment Epithelium (1998), Oxford University Press, New York 3-9
32. McCarroll J.A., Phillips P.A., Santucci N., Pirola R.C., Wilson J.S., and Apte M.V. Vitamin a inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut 55 (2006) 79-89
33. Miceli M.V., and Newsome D.A. Effects of extracellular matrix and Bruch's membrane on retinal outer segment phagocytosis by cultured human retinal pigment epithelium. Curr. Eye Res. 15 (1996) 17-26
34. Morino I., Hiscott P., McKechnie N., and Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br. J. Ophthalmol. 74 (1990) 393-399
35. Nagasaki H., Shinagawa K., and Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog. Retin. Eye Res. 17 (1998) 77-98
36. Parke II D.W., and Aaberg T.M. Intraocular argon laser photocoagulation in the management of severe proliferative vitreoretinopathy. Am. J. Ophthalmol. 97 (1984) 434-443
37. Pastor J.C. Proliferative vitreoretinopathy: an overview. Surv. Ophthalmol. 43 (1998) 3-18
38. Raymond M.C., and Thompson J.T. RPE-mediated collagen gel contraction. Inhibition by colchicine and stimulation by TGF-beta. Invest. Ophthalmol. Vis. Sci. 31 (1990) 1079-1086
39. Scarpa S., Giuffrida A., Palumbo C., Coletti A., Cerrito M.G., Vasaturo F., Sinibaldi P., Simonelli L., Procopio A., and Modesti A. Retinoic acid inhibits fibronectin and laminin synthesis and cell migration of human pleural mesothelioma in vitro. Oncol. Rep. 9 (2002) 205-209
40. Scheiffarth O.F., Kampik A., Gunther H., and von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch. Clin. Exp. Ophthalmol. 226 (1988) 357-361
41. Sell C.H., McCuen II B.W., Landers III M.B., and Machemer R. Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am. J. Ophthalmol. 103 (1987) 24-28
42. Seukeran D.C., and Cunliffe W.J. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br J Dermatol 139 (1998) 99-101
43. Sternberg Jr. P., and Machemer R. Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am. J. Ophthalmol. 100 (1985) 141-146
44. Verstraeten T., Hartzer M., Wilcox D.K., and Cheng M. Effects of vitamin a on retinal pigment epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2830-2838
45. Vinores S.A., Campochiaro P.A., and Conway B.P. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest. Ophthalmol. Vis. Sci. 31 (1990) 14-28
46. Webster L., Chignell A.H., and Limb G.A. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp. Eye Res. 68 (1999) 91-98
47. Wu W.C., Hu D.N., Mehta S., and Chang Y.C. Effects of retinoic acid on retinal pigment epithelium from excised membranes from proliferative vitreoretinopathy. J. Ocul. Pharmacol. Ther. 21 (2005) 44-54
48. Wu W.C., Hu D.N., and Roberts J.E. Phototoxicity of indocyanine green on human retinal pigment epithelium in vitro and its reduction by lutein. Photochem. Photobiol. 81 (2005) 537-540
49. Wu W.C., Kao Y.H., Hu P.S., and Chen J.H. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro. Exp. Eye Res. 85 (2007) 721-731
50. Yang C.H., Liu C.Z., Huang T.F., Yang C.M., Lui K.R., Chen M.S., and Hung P.T. Inhibition of RPE cell-mediated matrix adhesion and collagen gel contraction by crovidisin, a collagen-binding snake venom protein. Curr. Eye Res. 16 (1997) 1119-1126